Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
12.40
+0.09 (0.73%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $652.83 million as of October 29, 2024. Its market cap has increased by 260.28% in one year.
Market Cap
652.83M
Enterprise Value
376.68M
1-Year Change
260.28%
Ranking
Category
Stock Price
$12.40
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has decreased from $774.00M to $652.83M, a decrease of -15.65%. That is a compound annual growth rate of -3.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 648.10M | 175.90% |
| Dec 29, 2023 | 234.90M | -35.45% |
| Dec 30, 2022 | 363.90M | -58.77% |
| Dec 31, 2021 | 882.60M | -57.42% |
| Dec 31, 2020 | 2.07B | 123.63% |
| Dec 31, 2019 | 926.90M | 19.75% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Y-mAbs Therapeutics | 660.08M |
| IRADIMED CORPORATION | 659.21M |
| ABIVAX Société Anonyme | 659.00M |
| Alumis | 652.30M |
| EyePoint Pharmaceuticals | 648.64M |
| Mereo BioPharma Group | 645.14M |
| Avid Bioservices | 644.33M |
| Cytek Biosciences | 643.06M |